Abbott’s Anti-Seizure Drug Depakote Linked To Greater Risk Of Birth Defects
Get Legal Help Today
Secured with SHA-256 Encryption
UPDATED: Aug 5, 2019
It’s all about you. We want to help you make the right legal decisions.
We strive to help you make confident insurance and legal decisions. Finding trusted and reliable insurance quotes and legal advice should be easy. This doesn’t influence our content. Our opinions are our own.
Editorial Guidelines: We are a free online resource for anyone interested in learning more about legal topics and insurance. Our goal is to be an objective, third-party resource for everything legal and insurance related. We update our site regularly, and all content is reviewed by experts.
You may have heard of the anti-seizure drug, Depakote, in news reports linking the drug to the death of John Travolta’s son. However, it has also been linked to a greater risk of serious birth defects such as spina bifida, cleft palate, limb deformity, congenital cardiac defects, facial dysmorphism and others. Depakote lawyers say that numerous Depakote product liability lawsuits have been filed against the manufacturer and that more are likely.
What is Depakote?
Manufactured by Abbott Laboratories and approved by the U.S. Food & Drug Administration (FDA), Depakote, a neuronal stabilizing agent (aka anticonvulsant), is used to treat various types of seizure disorders such as epilepsy, manic phases of bipolar disorders (manic-depressive illness) and to prevent migraine headaches. It is also marketed by Abbott as Depacon and Depakene and generically as valproate sodium, valproic acid and divalproex sodium.
Depakote birth defects and side effects
According to a study by Haukeland University Hospital in Norway, pregnant women who are prescribed Depakote have a six percent greater chance of delivering a child with the following birth defects:
- Spina bifida
- Cleft palate
- Limb deformity
- Congenital cardiac defects
- Facial dysmorphism
Other studies, including one published in the New England Journal of Medicine (NEJM), show that Depakote use can lower a child’s IQ’s. The FDA has also warned Depakote patients that taking the drug carries a greater risk of suicidal thoughts and issued a black box warning, the strongest warning available, in January 2006 over concerns of hepatoxicity (chemical driven liver damage), teratogenicity (the capability of producing fetal malformation) and pancreatitis (the inflammation or infection of the pancreas).
Depakote birth defect lawsuits
Depakote attorneys indicate that numerous product liability lawsuits have been filed against the manufacturers alleging that they knew that these drugs were dangerous – yet have failed to warn consumers. If you or your child has been injured due to Depakote use, contact an experienced Depakote lawyer to discuss your situation.